Table 1

Characteristics of included studies

SNAuthorCountryCitation (doi)Study designAge range of study populationSource of data (primary or secondary)*Anthropometric measures usedMacronutrient intervention
1Bahwere et al38DRC/SSA10.1097/01.inf.0000135663.17018.51Prospective cohort<24/>=24 monthsPrimaryWHZYes; high energy food, enriched milk or F100
2Ashraf et al46Bangladesh/Asia10.1097/01.inf.0000135663.17018.51Randomised control trial2–59 monthsPrimaryWHZ, WAZEnriched milk
3Ngari et al5Kenya/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1111/ppe.12348Observational cohort1–59 monthsSecondaryMUAC, WHZ, WAZ, HAZNone
4Agweyu et al39Kenya/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1016/S2214-109X(17)30448-5Retrospective cohort2–59 monthsSecondaryMUAC, WAZ, WHZNone
5Awasthi et al40India/Asiahttps://doi-org.ezproxy.u-pec.fr/10.3389/fped.2021.790109Prospective observational cohort2–59 monthsPrimaryWAZNone
6Bekele et al43Ethiopia/SSAISSN 0971–9032 www.currentpediatrics.comCross-sectional2–59 monthsPrimaryMUACNone
7Bokadeet et al26India/Asiahttps://pmc-ncbi-nlm-nih-gov.ezproxy.u-pec.fr/articles/PMC4697219/Longitudinal cohort1–59 monthsPrimaryWAZNone
8Negash et al28Ethiopia/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1093/ofid/ofz029Observational cohort0–15 yearsPrimaryWAZNone
9Lazzerini et al25Malawi/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1016/S2214-109X(15)00215-6Retrospective Observational cohortUnder 5 years (we focus on 2–59 months)SecondaryWAZNone
10Nantanda et al44Uganda/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1179/146532808X375404Cross-sectional2–59 monthsPrimaryWHZ†None
11Macpherson
et al41
Kenya/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1136/bmjgh-2019-001715Retrospective Observational Cohort5–14 yearsSecondaryMUAC, WHZNone
12Eckerle et al27Malawi/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1136%2Fbmjpo-2021-001330Observational Cohort1–59 monthsPrimaryMUACNone
13Hooli et al16Malawi/SSAhttps://doi-org.ezproxy.u-pec.fr/10.1371/journal.pone.0168126Retrospective observational cohort0–59 months (focus on the 2–59 months)SecondaryWAZ, MUAC†None
14Kiguli et al45Uganda,
Kenya/SSA
https://doi-org.ezproxy.u-pec.fr/10.1016/j.eclinm.2024.102640Randomised control trial6 months–12 yearsPrimaryMUAC, WAZ, WHZ, triceps skinfold thicknessRUTF
15McCallum et al42Bangladesh/Asiahttps://doi-org.ezproxy.u-pec.fr/10.1016/S2213-2600(23)00098-XProspective observational cohort3–11 monthsPrimaryWAZ, MUAC†None
  • *Primary data were data collected by direct participant measurements, while secondary data were data extracted from participant/patient files or hospital records as reported by the individual studies.

  • †Author provided additional information.

  • DRC, Democratic Republic of Congo; HAZ, height-for-age z-score; MUAC, mid-upper arm circumference; RUTF, ready-to-use therapeutic food; SSA, sub-Saharan Africa; WAZ, weight-for-age z-score; WHZ, weight-for-height z-score.